This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Top market research firm: "A Gold Storm is Coming"](
Some of the richest men in the world are jumping in right now. One firm says: "We are in the early stages of a mania – the calm before the storm." [More here.](
--------------------------------------------------------------- December 28, 2023 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [Musk: My new robots could be bigger than Tesla](
No one can deny Elon Musk is a visionary. But has he finally gone too far? [>>See the shocking future of AI here<<]( --------------------------------------------------------------- [Townsquare Media](
Symbol: [TSQ](
Recent Price: $10.89
Average Analyst Price Target: $20.00 (56.11%)
Market Cap: $178.40M
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Feb 01 2024
Expected Dividend & Yield: 5.26% Recent Analyst Action: James Goss, analyst at Barrington, reiterates coverage on [Townsquare Media (TSQ)]( in the Communication Services sector with a Buy rating and a price target of $17 (1 month ago). [TipRanks.com]( also reports that [Townsquare Media]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.00 . The target pricing ranges from a high forecast of $23 down to a low forecast of $17. [Townsquare Media (TSQ)](’s last closing price was $10.89 which would put the average price target at 56.11% upside. Here are 3rd party ratings for [TSQ](: - TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 39% (153 out of 252)
[Click for chart >>](
--------------------------------------------------------------------------
---------------------------------------------------------------
Sponsor Message [Don't miss your 3rd and final chance!](
You missed your chance on Pfizer... ...which soared 600% after it released Lipitor in 1997. You missed your chance on Bristol Myers... ...which soared 500% after releasing Metformin in 1994. Both of these drugs broke records and made their investors rich. But there's one opportunity you didn't miss - and Morgan Stanley predicts it will be bigger than both of these combined! [Get all the details here.](
--------------------------------------------------------------- [Equity Residential](
Symbol: [EQR](
Recent Price: $61.87
Average Analyst Price Target: $64.25 (4.06%)
Market Cap: $24.04B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 12 2024
Expected Dividend & Yield: 4.27% Recent Analyst Action: Robert Stevenson, analyst at Janney Montgomery, reiterates coverage on [Equity Residential (EQR)]( in the Real Estate sector with a Hold rating and a price target of n/a (1 week ago). [TipRanks.com]( also reports that [Equity Residential]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $64.25 . The target pricing ranges from a high forecast of $71 down to a low forecast of $58. [Equity Residential (EQR)](’s last closing price was $61.87 which would put the average price target at 4.06% upside. Here are 3rd party ratings for [EQR](: - TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Bottom 40% (151 out of 252)
[Click for chart >>](
-------------------------------------------------------------------------- [Federal Realty](
Symbol: [FRT](
Recent Price: $104.81
Average Analyst Price Target: $108.00 (3.04%)
Market Cap: $8.61B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 16 2024
Expected Dividend & Yield: 4.16% Recent Analyst Action: Alexander Goldfarb, analyst at Piper Sandler, reiterates coverage on [Federal Realty (FRT)]( in the Real Estate sector with a Buy rating and a price target of $122 (1 week ago). [TipRanks.com]( also reports that [Federal Realty]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $108.00 . The target pricing ranges from a high forecast of $98 down to a low forecast of $103. [Federal Realty (FRT)](’s last closing price was $104.81 which would put the average price target at 3.04% upside. Here are 3rd party ratings for [FRT](: - TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 14% (36 out of 252)
[Click for chart >>](
--------------------------------------------------------------------------
---------------------------------------------------------------
Sponsor Message [ChatGPT, iOS and the Better AI Play...](
smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.](
--------------------------------------------------------------- [The Andersons](
Symbol: [ANDE](
Recent Price: $58.57
Average Analyst Price Target: $61.67 (6.71%)
Market Cap: $1.96B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 22 2024
Expected Dividend & Yield: 1.31% Recent Analyst Action: Ben Klieve, analyst at Lake Street, reiterates coverage on [The Andersons (ANDE)]( in the Industrials sector with a Buy rating and a price target of $60 (1 month ago). [TipRanks.com]( also reports that [The Andersons]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $61.67 . The target pricing ranges from a high forecast of $65 down to a low forecast of $60. [The Andersons (ANDE)](’s last closing price was $58.57 which would put the average price target at 6.71% upside. Here are 3rd party ratings for [ANDE](: - TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Bottom 33% (169 out of 252)
[Click for chart >>](
-------------------------------------------------------------------------- [Choice Hotels](
Symbol: [CHH](
Recent Price: $113.04
Average Analyst Price Target: $125.40 (13.49%)
Market Cap: $5.64B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 17 2024
Expected Dividend & Yield: 0.96% Recent Analyst Action: Brandt Montour, analyst at Barclays, reiterates coverage on [Choice Hotels (CHH)]( in the Consumer Cyclical sector with a Sell rating and a price target of $112 (1 week ago). [TipRanks.com]( also reports that [Choice Hotels]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $125.40 . The target pricing ranges from a high forecast of $140 down to a low forecast of $112. [Choice Hotels (CHH)](’s last closing price was $113.04 which would put the average price target at 13.49% upside. Here are 3rd party ratings for [CHH](: - TipRanks.com: Hold
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 33% (83 out of 252)
[Click for chart >>](
--------------------------------------------------------------------------
---------------------------------------------------------------
Sponsor Message [“Black Swan” Event Set to Crush Markets by January 2024](
Wall Street Legend Warns: What’s coming could [blindside]( millions of Americans. Take these [three critical steps]( now to prepare.
--------------------------------------------------------------- [Cardinal Health](
Symbol: [CAH](
Recent Price: $100.96
Average Analyst Price Target: $109.40 (5.17%)
Market Cap: $24.93B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 15 2024
Expected Dividend & Yield: 1.97% Recent Analyst Action: Steve Baxter, analyst at Wells Fargo, reiterates coverage on [Cardinal Health (CAH)]( in the Healthcare sector with a Sell rating and a price target of $96 (1 week ago). [TipRanks.com]( also reports that [Cardinal Health]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $109.40 . The target pricing ranges from a high forecast of $96 down to a low forecast of $105. [Cardinal Health (CAH)](’s last closing price was $100.96 which would put the average price target at 5.17% upside. Here are 3rd party ratings for [CAH](: - TipRanks.com: Hold
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Buy, Bottom 29% (180 out of 252)
[Click for chart >>](
-------------------------------------------------------------------------- [Ingredion](
Symbol: [INGR](
Recent Price: $108.75
Average Analyst Price Target: $120.40 (10.71%)
Market Cap: $7.12B
Expected Ex-Dividend Date: Dec 29 2023
Expected Payment Date: Jan 23 2024
Expected Dividend & Yield: 2.68% Recent Analyst Action: Cody Ross, analyst at UBS, reiterates coverage on [Ingredion (INGR)]( in the Consumer Defensive sector with a Buy rating and a price target of $136 (1 month ago). [TipRanks.com]( also reports that [Ingredion]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $120.40 . The target pricing ranges from a high forecast of $136 down to a low forecast of $110. [Ingredion (INGR)](’s last closing price was $108.75 which would put the average price target at 10.71% upside. Here are 3rd party ratings for [INGR](: - TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Buy, Top 38% (95 out of 252)
[Click for chart >>](
--------------------------------------------------------------------------
---------------------------------------------------------------
Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE](
for 3 Months FREE of
Bernie Schaeffer’s Option Advisor
($395 Retail Value - [FREE!]()
--------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC
165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software